Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia

Tohoku Journal of Experimental Medicine

Volumn 185, Issue 1, 1998, Pages 25-29

  Sato, Tokutaro ^a   Oouchi, Masao ^a   Nagakubo, Hiroari ^b   Chiba, Tooru ^b   Ogawa, Susumu ^b   Sato, Chiharu ^b   Sugimura, Kazuhiko ^b   Fukuda, Motosi ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesterol; Diabetes mellitus; Ketone bodies; Pravastatin

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETONE BODY; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; DIABETES CONTROL; DRUG EFFECT; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN ANALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; LIVER MICROSOME; LIVER MITOCHONDRION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031813090     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.185.25     Document Type: Article

References (17)

1. Hunninghake, D.B., Knopp, R.H., Schonfeld, G., Goldberg A.C., Brown, W.V., Schaefer, E.J., Margolis, S., Dobs, A.S., Mellies, M.J., Insall, W., Jr. & Stein, E.A. (1990) Efficacy and safety of pravastatin in patients with primary hypercholesterolemia: I. A dose response study. Atherosclerosis, 85, 81-89.
2. Ichihara, K., Satoh, K. & Abiko, Y. (1993) Influences of pravastatin, HMG-CoA reductase inhibitors, on myocardial stunning in dogs. J. Cardiovasc. Pharmacol., 22, 852-846.
3. Kjaer, K., Hangaard, J., Petersen, N.E. & Hagen, C. (1992) Effect of simvastatin in patients with type I (insulin-dependent) diabetes mellitus and hypercholesterolemia. Acta Endocrinol., 126, 229-232.
4. Koga, T., Shimada, Y., Kuroda, M., Tsujita, Y., Hasegawa, K. & Yamazaki, M. (1990) Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochem. Biophys. Acta, 1045, 115-120.
5. Koga, T., Fukuda, K., Shimada, Y., Fukami, M., Koike, H. & Tsujita, Y. (1992) Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. Eur. J. Biochem., 209, 315-319.
6. Komai, T., Shigehara, E., Tokui, T., Koga, T., Ishigami, M., Kuroiwa, C. & Horiuchi, S. (1992) Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture. Biochem. Pharmacol., 43, 667-670.
7. McGarry, J.D. & Foster, D.W. (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem., 49, 395-420.
8. McPherson, H.T., Werk, E.E., Myers, J.D. & Endel, F.L. (1958) Studies on ketone metabolism in men. II. The effect of glucose, insulin, cortisol and hypoglycemia on splanchnic ketone production. J. Clin. Invest., 37, 1379-1393.
9. Nakaya, N., Homma, Y., Tamachi, H. & Goto, Y. (1986) The effect of CS-514, an inhibitor of HMG-CoA reductase, on serum lipids in healthy volunteers. Atherosclerosis, 61, 125-128.
10. Paolisso, G., Sgambato, S., De Riu, S., Gambardella, A., Verza, M., Varricchio, M. & D'Onofrio, F. (1991) Simbastatin reduces plasma lipid levels and improves insulin action in elderly, non-insulin dependent diabetics. Eur. J. Clin. Pharmacol., 40, 27-31.
11. Parker, R.A., Clark, R.W., Sit, S.Y., Lanier, T.L., Grosso, R.A. & Wright, J.J.K. (1990) Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors. J. Lipid Res., 31, 1271-1282.
12. Satoh, K., Nakai, T. & Ichihara, K. (1994) Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in rat liver during ischemia Eur. J. Pharmacol./Enviro. Toxicol. Pharmacol., 270, 365-369.
13. Satoh, K., Yamamoto, A., Nakai, T., Hoshi, K. & Ichihara, K. (1995) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts. Br. J. Pharmacol., 116, 1894-1898.
14. Sheu, W.H., Shieh, S.M, Shen, D.D., Fuh, M.M., Jeng, C.Y., Chen, Y.I. & Reaven, G.M. (1994) Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia. Am. J. Heart Disease, 127, 331-336.
15. Tsujita, Y., Kuroda, M., Shimada, Y., Tanzawa, K., Arai, M., Kaneko, I., Tanaka, M., Masuda, H., Tarui, C., Watanabe, Y. & Fujii, S. (1986) CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: Tissue-selective inhibition of steroid synthesis and hypolipidemic effects on various animal species. Biochem. Biophys. Acta, 877, 50-60.
16. Yoshino, G., Kazumi, J., Uenoyama, R., Inui, A., Kasama, T., Iwatani, I., Iwai, M., Yokono, K., Otsuki, M. & Baba, S. (1986) Probucol versus eptastatin in hypercholesterolaemic diabetics. Lancet, 2, 740-741.
17. Zhang, A., Vertommen, L., Van Gaal, L. & De Leeuw, I.R. (1995) Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients. Diabetes Res. Clin. Pract, 29, 189-194.